Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Steele-Richardson-Olszewski syndrome]

¹Department of Neurology, Nara Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|November 1, 1993

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

C-reactive protein : albumin ratio in patients with resectable intrahepatic cholangiocarcinoma.

BJS open·2020

Same author

Right hepatic venous system variation in living donors: a three-dimensional CT analysis.

The British journal of surgery·2020

Same author

Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection.

BJS open·2019

Same author

Rendezvous Technique Using Double Balloon Endoscope for Removal of Multiple Intrahepatic Bile Duct Stones in Hepaticojejunostomy After Living Donor Liver Transplant: A Case Report.

Transplantation proceedings·2019

Same author

Real-Time Ultrasound-Guided Thrombectomy for Extensive Portal Vein Thrombosis in Living Donor Liver Transplantation.

Transplantation proceedings·2018

Same author

Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.

Journal of gastroenterology and hepatology·2017

Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019

See all related articles

Steel-Richardson-Olszewski syndrome, or progressive supranuclear palsy (PSP), is often overlooked despite its distinct symptoms. Research explores neurotransmitter abnormalities and novel treatments like transplantation for this complex neurological disorder.

Area of Science:

Neuroscience
Neurology

Context:

Progressive supranuclear palsy (PSP), also known as Steel-Richardson-Olszewski syndrome, presents unique diagnostic challenges.
While the full syndrome is distinct, atypical presentations without axial dystonia or ophthalmic signs can lead to misdiagnosis or delayed identification.

Purpose:

To review the broader abnormalities associated with PSP beyond the dopamine system.
To discuss the limitations of current neurotransmitter replacement therapies.
To highlight emerging treatment strategies for PSP.

Summary:

PSP involves neurotransmitter and neuromodulator system abnormalities extending beyond dopamine, affecting serotonin and acetylcholine pathways.
Previous trials of neurotransmitter replacement have yielded limited success.

Related Experiment Videos

Current research investigates advanced treatments, including cell transplantation and nerve growth factor administration.

Impact:

Improved understanding of PSP's complex neurochemical underpinnings.
Identification of challenges in current therapeutic approaches for PSP.
Paving the way for innovative treatment modalities in progressive supranuclear palsy management.